Calcium problems in memory circuits in Alzheimer's

Calcium dysregulation and vulnerability of entorhinal cortex neurons in Alzheimer's disease

NIH-funded research Ut Southwestern Medical Center · NIH-11317170

This project aims to fix calcium signaling in key brain cells to help protect memory circuits in people with early Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-11317170 on NIH RePORTER

What this research studies

Researchers will use a well-known mouse model of Alzheimer's to study why neurons in the lateral entorhinal cortex, which connect to the hippocampus, lose their synapses early in the disease. They will focus on two proteins, the calcium-activated enzyme calcineurin and the regulator Pin1, to see if normalizing their activity preserves cell connections and memory-related function. The team will combine molecular tests, imaging, electrical recordings, behavior tests, and tissue analysis to track circuit health and timing of decline. Findings will be used to judge whether drugs that target calcineurin or related pathways might be worth testing in people.

Who could benefit from this research

Good fit: People with early-stage Alzheimer's disease or mild cognitive impairment affecting memory would be the most likely beneficiaries of therapies that come from this work.

Not a fit: People with non-Alzheimer dementias or very advanced Alzheimer's disease are unlikely to benefit directly from findings focused on early circuit changes.

Why it matters

Potential benefit: If successful, this work could point to treatments that stabilize calcium signaling and slow early memory-circuit loss in Alzheimer's.

How similar studies have performed: Related animal studies have suggested calcineurin and Pin1 affect synapses and memory, but these approaches are not yet proven in human trials.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease model
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.